Lettmann Jason — SEC Form 4 filings
SEC reporting owner CIK 1688269. 14 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-02-16 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 96,633 shares, $149,124 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 19,082 shares, $35,027 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: purchase of 71,163 shares @ $1.08 ($76,892) in ALX ONCOLOGY HOLDINGS INC, filed 2025-09-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | CHIEF EXECUTIVE OFFICER, Director | 14 | 3 legs · 96,633 sh · $149,124 | 4 legs · 19,082 sh · $35,027 | 9 |
Form 4 filings — Lettmann Jason
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Sale (S): 2,230 @ $1.93 | EDGAR |
| 2026-03-23 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Sale (S): 12,311 @ $2.17 | EDGAR |
| 2026-02-19 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Tax withholding (F): 2,201 @ $2.27 | EDGAR |
| 2026-01-28 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 912,000 (derivative) @ $0 | EDGAR |
| 2025-10-16 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 597,500 (derivative) @ $0 | EDGAR |
| 2025-09-18 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Purchase (P): 21,070 @ $1.07 · Purchase (P): 71,163 @ $1.08 | EDGAR |
| 2025-08-19 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Sale (S): 2,382 @ $0.64 | EDGAR |
| 2025-04-15 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 42,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Sale (S): 2,159 @ $1.15 | EDGAR |
| 2024-12-04 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-08-16 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Tax withholding (F): 2,191 @ $2.58 | EDGAR |
| 2024-03-18 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Purchase (P): 4,400 @ $11.31 | EDGAR |
| 2024-02-16 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 60,000 @ $0 · Grant/award (A): 190,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1688269 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →